Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases - Koulova, L; Alexandrescu, D; Dutcher, JP (Am J Hematol, 2005)
et al.